Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thiol:disulfide interchange protein DsbA is a critical periplasmic enzyme found in Gram-negative bacteria, where it serves as the primary catalyst for the formation of disulfide bonds in proteins [2, 11]. As a member of the thioredoxin-like superfamily, DsbA possesses a highly oxidizing redox potential, allowing it to efficiently transfer disulfide bonds to nascent polypeptides as they enter the periplasm [7, 12]. This oxidative folding is essential for the structural integrity and functional maturation of numerous virulence factors, including toxins, adhesins, and secretion system components [3, 10]. Consequently, DsbA is a major determinant of bacterial pathogenesis across a wide range of species, such as Escherichia coli, Pseudomonas aeruginosa, and Vibrio cholerae [9, 15]. Because DsbA is required for virulence but typically not for bacterial viability, it is considered an attractive target for the development of anti-virulence drugs [3, 4]. Such agents aim to disarm the pathogen without exerting the intense selective pressure that drives the emergence of antibiotic resistance [6, 13]. Current drug discovery efforts focus on small molecules, including covalent inhibitors and peptidomimetics, that block the DsbA active site or its substrate-binding groove [4, 9].
Inhibition of DsbA-mediated oxidative folding of bacterial virulence factors, thereby attenuating pathogenesis without affecting bacterial viability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thiol:disulfide interchange protein DsbA (DsbA).